Navigation Links
ANA598 Data Presented at AASLD Highlight Positive Clinical Profile of DAA Entering Phase IIb
Date:10/30/2010

2, 2010, Anadys will present additional data from the Phase II combination study showing that the addition of ANA598 to SOC conferred benefit independent of a patient's IL-28B genotype. In patients with the IL-28B genotype most responsive to SOC (referred to as CC), ANA598 accelerated the rate of achieving undetectable levels of virus, with 82% of patients who received ANA598 plus SOC achieving undetectable levels by week 4, compared to 27% of patients who received placebo plus SOC.  In patients with IL-28B genotypes less responsive to SOC (referred to as CT and TT, or collectively non-CC), ANA598 both accelerated the rate of achieving undetectable levels of virus and increased the percentage of patients with undetectable levels of virus at week 12.  In the non-CC patients, 38% of patients who received ANA598 plus SOC achieved undetectable levels of virus by week 4, compared to 8% of patients who received placebo plus SOC, and 73% of patients who received ANA598 plus SOC achieved undetectable levels of virus at week 12, compared to 47% of patients who received placebo plus SOC.  

Phase II Combination Study

In the ongoing Phase II study, approximately 90 treatment-naive genotype 1 HCV patients have received ANA598 or placebo in combination with Pegasys® (peginterferon alfa-2a) and Copegus® (ribavirin, USP) for 12 weeks at dose levels of 200 mg twice-daily (bid) or 400 mg bid, each with a loading dose of 800 mg bid on day one. After week 12, patients are to continue receiving SOC. Patients who achieved undetectable levels of virus at weeks 4 and 12 were randomized to stop all treatment at week 24 or 48. The primary endpoint of the study is the proportion of patients who achieve undetectable levels of virus at week 12 (defined as complete Early Virological Response, or cEVR). Additional endpoints include safety and tolerability as well as the proportion of patients with undetectable levels of v
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
6. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
7. ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
8. ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
9. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
10. ANA598 Demonstrates Positive 4-Week Results at 200 mg BID
11. ANA598 Demonstrates SVR12 in 100% of First Group of HCV Patients Randomized to Stop All Treatment at Week 24
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... CITY, Calif. , Nov. 26, 2014  Genomic ... Kim Popovits , Chairman, Chief Executive Officer and ... Piper Jaffray Healthcare Conference at The New York Palace ... Wednesday, December 3 at 11:30 am Eastern Time (ET). ... webcast of the conference call, go to the  Investor ...
(Date:11/26/2014)... Nov. 26, 2014  Avanir Pharmaceuticals, Inc. (NASDAQ: ... Food and Drug Administration (FDA) has issued a ... (NDA) for AVP-825. AVP-825 is an investigational drug-device ... intranasally utilizing a novel Breath Powered delivery technology. ... and consistent with the preliminary feedback announced on ...
(Date:11/26/2014)... 2014 Scott Steiger lives in ... As an engineer for the past 20 years, he,s traveled extensively ... service. He,s been to six of the seven continents. Travel is ... http://photos.prnewswire.com/prnh/20141126/161076 Photo - http://photos.prnewswire.com/prnh/20141126/161077 ... a pretty good idea of what,s required. His latest ...
Breaking Medicine Technology:Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 2Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 4Steiger Has Created the First Pill Case Specifically Designed For Travel 2
(Date:11/28/2014)... (PRWEB) November 29, 2014 ... Informatics has encouraged research in all the ... medicine, clinical decision support and population health ... integrates most recent innovation in machine learning, ... , View full report with full ...
(Date:11/28/2014)... 29, 2014 TideStore.com , has taken ... dresses, shoes and other fashion items recently. Its 2014 Cyber ... , The special offer is valid during Nov. 30 ... stylish women outwears, charming dresses, shining prom shoes, essential women’s ... online store offering many trendy clothes and fashion accessories. Its ...
(Date:11/28/2014)... BellasDress , a renowned dress manufacturer in the international market, ... dresses. In addition, these fresh dresses are available at discounted ... orders over $179. The aim of the special offer is ... styles of dresses, which come in various colors; these models ... of them are on sale at affordable prices. ...
(Date:11/28/2014)... Angelweddingdress.com, a world-famous dress manufacturer ... Blue Color Styles of Bridesmaid Dresses ... 80% off and free shipping on orders over ... bridesmaid dresses for less at the online store ... famous as a reliable dress supplier in the ...
(Date:11/28/2014)... The month of December has the highest occurrence ... in Florida every year in December , attorney Sean M. ... policies. , "Optional auto insurance coverage is something you think ... I know, actually Florida is among the states, where due ... what I see is that the insurance required by law ...
Breaking Medicine News(10 mins):Health News:Medical & Healthcare Analytics Market Report: Global Industry Size, Share, Trends, Growth and Forecast by Researchmoz.us 2Health News:2014 Special Monday Sales from TideStore.com 2Health News:BellasDress Offers A Big Surprise By Updating Its Cheap and Charming Cocktail Dresses 2Health News:Blue Color Styles of Bridesmaid Dresses from AngelWeddingDress.com are Available Now With Big Discounts 2Health News:Car Accident Attorney Sean M. Cleary on Auto Insurance Policies Essential for Florida Drivers 2
... achieved such a central place in public consciousness as ... it is a feared weapon of bioterrorism Bacillus anthracis ... research of the celebrated 19th century scientists Robert Koch ... diseases and immunology In his new book Bacillus ...
... are reporting the development of a new, ultra-light form ... solid material with amazing strength and an incredibly ... (MCNT) aerogel" could be used in sensors to detect ... A report about the material appears in ACS ...
... more persistent memory of fear conditioning - acquired by ... and lack the ability to inhibit this fear. This ... from Post-Traumatic Stress Disorder (PTSD), an anxiety disorder which ... as a violent attack, a natural disaster or physical ...
... kilos you,ve put on over Christmas, you may be interested in ... in your likelihood of regaining weight after dieting. A new study ... levels of ghrelin are more likely to put the centimetres they ... patients who, after sticking to a slimming diet, have regained the ...
... vital tumor-suppressing mechanism that is often broken in malignant ... goes haywire to stimulate cancer growth have earned two ... Center membership in a distinguished association of scholars. ... and chair of MD Anderson,s Department of Molecular and ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, Jan. ... heart failure patients taking the blood pressure drug candesartan stood ... Swedish researchers report. In fact, 61 percent of those ... taking losartan (Cozaar); this difference may be due to differences ...
Cached Medicine News:Health News:'Bacillus anthracis and Anthrax' 2Health News:Drug reduces the increase in fear caused by previous traumatic experiences in mice 2Health News:'Yo-yo' effect of slimming diets explained 2Health News:Peers elect MD Anderson's Hung and Lozano as Fellows of AAAS 2Health News:Peers elect MD Anderson's Hung and Lozano as Fellows of AAAS 3Health News:Not All Heart Failure Drugs Boost Survival Equally 2
... Korchek Technologies CareChek Tx, ... as a software device for ... to match the patient to ... the bedside before administering a ...
... 140XiIII is the fastest barcoding printer ... such powerful performance and steel construction, ... high-volume, mission-critical applications with 24-hour duty ... for applications in which labels are ...
... you use technology that improves patient outcomes. ... simple-to-use BD.id Patient Identification System for Specimen ... the specimen container, and the order of ... only for specimens actually collected, with both ...
... ID verification and laboratory specimen labeling system uses ... phlebotomist or nurse, the identity of the patient ... is made, a bar coded sample ID label ... design simplifies and eliminates the interface problems inherent ...
Medicine Products: